Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000819050-22-000092
Filing Date
2022-06-07
Accepted
2022-06-07 16:28:41
Documents
1
Effectiveness Date
2022-06-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 13234
  Complete submission text file 0000819050-22-000092.txt   14472
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-448413 | Film No.: 221001513
SIC: 2836 Biological Products, (No Diagnostic Substances)